πŸ‡ΊπŸ‡Έ FDA
Patent

US 7879564

Use of the receptor GPR86

granted A61KA61K49/0008A61P

Quick answer

US patent 7879564 (Use of the receptor GPR86) held by Takeda Pharmaceutical Company Limited expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K49/0008, A61P, A61P37/00